Nixon Peabody Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268K | Buy |
+2,588
| New | +$231K | 0.02% | 165 |
|
|
2024
Q2 | – | Sell |
-2,945
| Closed | -$235K | – | 131 |
|
|
2024
Q1 | $235K | Sell |
2,945
-952
| -24% | -$72.7K | 0.02% | 117 |
|
|
2023
Q4 | $308K | Buy |
+3,897
| New | +$277K | 0.03% | 105 |
|
|
2023
Q3 | – | Sell |
-13,790
| Closed | -$953K | – | 80 |
|
|
2023
Q2 | $953K | Sell |
13,790
-10,596
| -43% | -$754K | 0.77% | 48 |
|
|
2023
Q1 | $1.81M | Buy |
24,386
+2,718
| +13% | +$228K | 1.27% | 42 |
|
|
2022
Q4 | $2.02M | Sell |
21,668
-72
| -0.3% | -$6.95K | 1.64% | 24 |
|
|
2022
Q3 | $2.07M | Sell |
21,740
-14,884
| -41% | -$1.47M | 1.76% | 17 |
|
|
2022
Q2 | $3.39M | Sell |
36,624
-10,939
| -23% | -$1.07M | 1.53% | 28 |
|
|
2022
Q1 | $4.81M | Sell |
47,563
-8,080
| -15% | -$849K | 1.66% | 22 |
|
|
2021
Q4 | $5.74M | Buy |
55,643
+1,909
| +4% | +$176K | 1.74% | 20 |
|
|
2021
Q3 | $4.56M | Sell |
53,734
-5,335
| -9% | -$447K | 1.65% | 26 |
|
|
2021
Q2 | $4.93M | Sell |
59,069
-269
| -0.5% | -$22K | 1.9% | 23 |
|
|
2021
Q1 | $4.46M | Sell |
59,338
-1,227
| -2% | -$89.4K | 1.81% | 23 |
|
|
2020
Q4 | $4.14M | Sell |
60,565
-585
| -1% | -$38K | 1.75% | 25 |
|
|
2020
Q3 | $3.57M | Buy |
61,150
+2,577
| +4% | +$160K | 1.64% | 27 |
|
|
2020
Q2 | $3.81M | Buy |
58,573
+280
| +0.5% | +$17.6K | 1.93% | 21 |
|
|
2020
Q1 | $3.46M | Buy |
58,293
+143
| +0.2% | +$9.55K | 2.14% | 17 |
|
|
2019
Q4 | $4.32M | Sell |
58,150
-3,676
| -6% | -$258K | 2.15% | 18 |
|
|
2019
Q3 | $3.9M | Buy |
61,826
+4,954
| +9% | +$294K | 2.08% | 19 |
|
|
2019
Q2 | $3.1M | Buy |
56,872
+11,945
| +27% | +$643K | 1.75% | 30 |
|
|
2019
Q1 | $2.42M | Buy |
44,927
+8,187
| +22% | +$505K | 1.59% | 31 |
|
|
2018
Q4 | $2.41M | Sell |
36,740
-910
| -2% | -$67.9K | 1.9% | 25 |
|
|
2018
Q3 | $2.96M | Buy |
37,650
+2,304
| +7% | +$165K | 2.03% | 20 |
|
|
2018
Q2 | $2.27M | Buy |
35,346
+2,219
| +7% | +$146K | 1.76% | 26 |
|
|
2018
Q1 | $2.06M | Buy |
33,127
+1,570
| +5% | +$113K | 1.85% | 26 |
|
|
2017
Q4 | $2.29M | Buy |
31,557
+1,040
| +3% | +$75.6K | 1.97% | 24 |
|
|
2017
Q3 | $2.48M | Sell |
30,517
-15
| -0% | -$1.19K | 2.25% | 15 |
|
|
2017
Q2 | $2.46M | Buy |
30,532
+775
| +3% | +$61.2K | 2.27% | 15 |
|
|
2017
Q1 | $2.34M | Buy |
29,757
+1,133
| +4% | +$90.5K | 2.2% | 16 |
|
|
2016
Q4 | $2.26M | Buy |
28,624
+2,030
| +8% | +$164K | 2.2% | 15 |
|
|
2016
Q3 | $2.37M | Sell |
26,594
-1,919
| -7% | -$181K | 2.32% | 11 |
|
|
2016
Q2 | $2.73M | Buy |
28,513
+395
| +1% | +$39.4K | 2.37% | 11 |
|
|
2016
Q1 | $2.92M | Buy |
28,118
+345
| +1% | +$33.5K | 2.59% | 8 |
|
|
2015
Q4 | $2.71M | Buy |
+27,773
| New | +$2.72M | 2.47% | 8 |
|
Other funds holding CVS
CF
HCM
Nixon Peabody Trust's CVS Position: Q2 2026 in Review
Nixon Peabody Trust opened a new position in CVS Health (CVS) in Q2 2026: 2,588 shares worth $268K. The stake represents 0.02% of the portfolio and ranks #165 among its holdings. This is a return to the name: Nixon Peabody Trust previously reported a position in CVS as recently as Q1 2024.
Nixon Peabody Trust first reported a position in CVS in Q4 2015 and has held it in 34 quarters since. The position peaked at $5.74M in Q4 2021. 783 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Nixon Peabody Trust held 2,588 shares of CVS Health worth $268K as of Q2 2026.
- CVS Health was a new Nixon Peabody Trust position in Q2 2026.
- CVS Health made up 0.02% of Nixon Peabody Trust's portfolio in Q2 2026, its #165 holding.
- Nixon Peabody Trust first reported a position in CVS Health in Q4 2015 and has held it in 34 quarters since.
- Nixon Peabody Trust's CVS Health position peaked at $5.74M in Q4 2021.
- 783 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.